ACIP Presentation Slides: June 23-25, 2021 Meeting

Note: These files are not yet 508

Slides will be added as they become available.

June 23, 2021

Welcome & Introductions

• Introduction
  Dr. J Romero
  Dr. A Cohn

Coronavirus Disease 2019 (COVID-19) Vaccines

• Introduction pdf icon[14 pages]
  Dr. M Daley
  
• Overview of myocarditis and pericarditis pdf icon[12 pages]
  Dr. M Oster
• Update on COVID-19 vaccine safety, including myocarditis after mRNA vaccines pdf icon[51 pages]
  Dr. T Shimabukuro
• VaST assessement pdf icon[13 pages]
  Dr. G Lee
• COVID-19 mRNA vaccines in adolescents and young adults: benefit-risk discussion pdf icon[44 pages]
  Dr. M Wallace
• Overview of data to inform recommendations for additional doses of COVID-19 vaccines pdf icon[56 pages]
  Dr. S Oliver

June 24, 2021

Welcome & Introductions

• Welcome and Introductions
  Dr. J Romero
  Dr. A Cohn

Dengue Vaccine

• Introduction pdf icon[8 pages]
  Dr. W Chen
• Acceptability of dengue vaccine in Puerto Rico pdf icon[31 pages]
  Dr. I Esquilin
• Implementation of dengue vaccine in Puerto Rico pdf icon[28 pages]
  Dr. I Cardona
• Dengue vaccine draft recommendations using the evidence to recommendation framework pdf icon[57 pages]
  Dr. G Paz-Bailey
• Dengue VFC Resolution pdf icon[6 pages]
  Dr. J Santoli

Influenza Vaccines

• Introduction pdf icon[4 pages]
  Dr. K Talbot
• Flucelvax Quadrivalent (ccIIV4) Phase III Randomized Controlled Trial—Immunogenicity and Safety in Children 6 through 47 months pdf icon[14 pages]
  Dr. G Sylvester
• Work group considerations and proposed recommendations for the 2021-22 Influenza Season pdf icon[33 pages]
  Dr. L Grohskopf
• Updates to Influenza VFC Resolution
  Dr. J Santoli

Rabies Vaccines

• Introduction pdf icon[8 pages]
  Dr. S Frey
• Rabies immune globulin pdf icon[20 pages]
  Dr. A Rao
• Rabies post-exposure prophylaxis schedule pdf icon[25 pages]
  Dr. A Rao
• Rabies pre-exposure prophylaxis: GRADE/EtR summary pdf icon[30 pages]
  Dr. A Rao

June 25, 2021

Welcome & Introductions

• Welcome and Introductions
  Dr. J Romero
  Dr. A Cohn

Zoster Vaccine

• Introduction pdf icon[8 pages]
  Dr. G Lee
• Burden of herpes zoster in immunocompromised adults pdf icon[20 pages]
  Dr. T Anderson
• Use of recombinant zoster vaccine in immunocompromised populations: overview of clinical program pdf icon[22 pages]
  Dr. R Widenmaier

Pneumococcal Vaccine

• Introduction pdf icon[14 pages]
  Dr. K Poehling
• Updates on epidemiology of invasive pneumococcal disease in U.S. adults pdf icon[18 pages]
  Dr. R Gierke
• Cost effectiveness of PCV15 and PCV20 use in U.S. adults pdf icon[31 pages]
  Dr. C Stoecker
• GRADE for age-based PCV15 and PCV20 use in U.S. adults pdf icon[35 pages]
  Dr. J Farrar
• EtR summary of age-based PCV15 and PCV20 use in U.S. adults pdf icon[97 pages]
  Dr. M Kobayashi
• Summary and timeline
  Dr. M Kobayashi